About
Current Employment: Clinical Services Director, Children's Hospital Los Angeles, CA
Education
2011
PhD, University of California, School of Nursing, Los Angles, CA
1988
MSN, University of Pittsburgh, School of Nursing, Parent/Child Nursing, Pediatric Oncology Specialty
1983
BSN, Carlow College, School of Nursing, Pittsburgh, PA
Grants
2010
NIHAHRQ Predoctoral Grant Award - Funded, $40,000
2010
American Cancer Society Doctoral Award - Funded, $30,000
2009
Alex Lemonade Stand Foundation Nursing Research Grant - Funded, $26,300
Honors and Awards
1986
Nominee Nurse of the Year, Children's Hospital of Pittsburgh (CHP), PA
1994
Nursing Excellence Award for Pediatric Oncology Education, Association Of Pediatric Oncology Nurses (APON)
1996
APON Leadership recognition award, APON
1997
Nominee for California Nurseweek Excellence Award, CHLA
1999
Safety Awareness Award, CHLA
1999
University of Southern California (USC) Team Excellence Award RN Internship CHLA
1999
Nominated for the Casey Hooke APON leadership Award, APON
2004
President Elect, APON
2005
Nominated CHLA Humanism Award, CHLA
2005
Clinical Practice Recognition Awards, Children's Oncology Group (COG) Nursing Discipline
2005
President, APHON
2005
Nominated Nursing Excellence Award, Nursing Spectrum California
2005
Runner up Nurse Best Leader Award, Advance for Nurses, Southern California Region
2007
Recipient Kathy Ruccione Founder's Award for Excellence in Pediatric Hematology/Oncology Nursing, Southern California Association of Pediatric Hematology Oncology Nurses (SCAPHON), San Diego, CA
2008
Recipient Association of California Nurse Leaders (ACNL) Gretta Styles Doctoral Scholarship Award, ACNL, Palm Desert, CA
2008
Recipient Oncology Nursing Society (ONS) Foundation Robert Pierce Scofield Doctoral Academic Scholarship, ONS, Pittsburgh, PA
2008
Recipient CHLA Daisy Award May 2008, CHLA
2008
Recipient J&J Future of Southern California Faculty Nursing Education Scholarship
2008/2009
Nominated for California Nurseweek Excellence Award Leading and Advancing the Profession, CHLA
2010
California Nurseweek Excellence Award Finalist, Leading and Advancing the Profession
2010
Recipient 2010 APHON Casey Hooke Leadership Service Award, APHON
2011
California Nurseweek Excellence Award Finalist, Leading and Advancing the Profession
2012
Recipient 2012 APHON Writing Award, APHON
2013
Inductee 2013 Fellow in the American Academy of Nursing, FAAN
2017
Recognition Top RN in Los Angeles, Worldwide Leaders in Healthcare, International Nurses Association
Publications
Peer Reviewed, Invited, Monographs
2015 Secola, R. Marachelian, A., Cohn, S. L., Toy, B., Neville, K., Granger, M. P., Brentlinger, A., Martin, G. The role of nursing professionals in the management of patients with high-risk neuroblastoma receiving dinutuximab therapy. JOPON, In Peer Review. 2015 Darezzo Rodrigues Nunes, M., Jacob, E. Adlard, K., Secola , R., Castanheira Nascimento, L. Fatigue and sleep experience at home in children and adolescents with cancer. Oncology Nursing Forum, 42 (5), 498-506. 2013 Secola, R. Targeted Therapy in Children and Adolescents with Cancer. APHON Counts, Fall, 2013. 2013 Altounji, D. Morgan, H., Grover, M., Dalduyman, S., Secola, R. Self Care: What it means to the pediatric hematology oncology nurse. Journal of Pediatric Oncology Nursing, 30 (1), 18-23. 2012 Secola, R. Azen, C., Lewis, MA, Needleman, J., Pike, N., Sposto, R., Doering, L. A Crossover Randomized Prospective Pilot Study Evaluating a Central Venous Catheter Team in Reducing Catheter-Related Bloodstream Infections In Pediatric Oncology Patients. Journal of Pediatric Oncology Nursing, 29 (6), 307-315. 2012 Secola, R., Lewis, M.A., Pike, N., Needleman, J. Doering, L. (2012). “Targeting to Zero” in Pediatric Oncology: A Review of Central Venous Catheter-Related Bloodstream Infections. Journal of Pediatric Oncology Nursing, 29 (1), 14-27. 2012 Secola, R., Lewis, M.A., Pike, N., Needleman, J., Doering, L. (2012). Feasibility of the Use of a Reliable and Valid Central Venous Catheter Blood Draw Checklist. Journal of Nursing Care Quality, 27 (30), 218-225. 2010 Fichera, S., Hackett, H., & Secola, R. Perinatal germ cell tumors: A case report of a cervical teratoma. Advances in Neonatal Care. 2010 June; 10(3): 133-9. 2010 Kanathezhath, B., Shah, A. J., Secola, R., Hudes, M., Feusner, J. H. The utility of routine surveillance blood cultures in asymptomatic hematopoietic stem cell transplant patients. Journal of Pediatric Hematology Oncology.2010 May; 32(4): 327-31. 2009 Angiolilo, A., Ingle, A. A., Yu, A., Secola, R., Reaman, G. H., Adamson, A. A Phase II study of campath-1H in children with ALL in second or refractory relapse. Pediatric Blood and Cancer,2009 Dec; 53(6):978-83. 2007 Secola, R. (2007). Overview of ITP Diagnosis and Current Treatment Modalities, Online Continuing Education Study Program, Baxter Healthcare and Blitz Associates. 2006 Secola, R. (2006). Tumor Lysis Syndrome: Nursing Management and New Treatment Options. John Hopkins Advanced Studies in Nursing, 4(3), 41-48. 2005-2007 President’s Pens, Issue themes, APHON Counts Newsletters. 2004 Cairo, M.S., Davenport, V., Bessmertny, O., Goldman, S., Berg, S., Kreissman, S.G., Laver, J., Shen, V., Secola, R., van de ven, C., Reaman, G.H. (2004). A Phase I/II trial of recombinant human Interleukin-11 (Neumega) following Ifosfamide, Carboplatin, Etoposide (ICE) in children and adolescents with solid tumors or lymphoma: a clinical, haematological and biological study. British Journal of Haematology, 128(1), 49-58. 2001 Secola, R. (2001). Hematopoietic stem cell transplantation: A glimpse of the past and a view of the future. JOPON, 18(4), 171-177. 2001 Bracho, F., Krailo, M., Shen, V., Bergeron, S., Davenport, V., Mares, W.L., Blazar, B. R., Mortari, A. P., van de Ven , C., Secola, R., Ames, M. M., Reid, J. M., Reaman, G., Cairo, M.(2001). A Phase I Clinical, Pharmacological and Biological Trial of Interleukin-6 Plus Granulocyte-Colony Stimulating Factor after Ifosfamide, Carboplatin, and Etoposide in Children with Recurrent/Refractory Solid Tumors: Enhanced Hematological Responses but a High Incidence of Grade III/IV Constitutional Toxicities. Clinical Cancer Research, 7, 58-67. 2000 Secola, R., Derrickson, J., Reid, D. (2000). Establishing RN competency for the administration of sedation and analgesia to pediatric oncology patients. JOPON, 17, 124-126. 1999 Ethyol Amifostine, Secola, R., JAPON Summer Issue. 1999 Ethoyl Amifostine, Secola, R., CCG Nursing Newsletter. 1998 Abstract-Videotaped Instruction for Primary Caretakers of Pediatric Oncology Patients JAPON Winter, 1998 (Secola,R., Adlard, K.). 1998 Cairo, M. S., Krailo, Weinthal, J. A., Secola, R., Bergeron, S., van de Ven, C., Blazar, B.R., Garrison, L., Reaman, G. H. (1998). A Phase I study of granulocyte-macrophage- colony stimulating factor/interleukin-3 fusion protein (PIXY321) following ifosfamide, carboplatin, and etoposide therapy for children with recurrent or refractory solid tumors A report of the Children's Cancer Group. Cancer 83 (7), 1449 -1460. 1997 Secola, R. (1997). Pediatric Blood Cell Transplantation. Seminars in Oncology Nursing, 13(3), 184-193. 1996 Rosenthal, J., Sender, L., Secola, R., Killen, R., Millerick, M. Murphy, L., Cairo, M. S. (1996). A Phase II trial of heparin prophylaxis for veno-occlusive disease (VOD) of the liver in children undergoing bone marrow transplantation, Bone Marrow Transplantation, 18(1), 185-191. 1996 Abstract - The Safety and Efficacy of Repetitive Peripheral Stem Cell Support in Children Receiving Sub-myeloablative Chemotherapy, Shen, V. et. al., American Association for Cancer Research, 1994. 1994 Abstract "The Use of Colony Stimulating Factors In Children", Secola. R., JAPON, May 1994. 1993 Secola, R. (1993). PIXY 321(GM-CSF/IL-3 Fusion Protein). JOPON, 10(3), 117-118.